Top Biotechnology companies in United States by EBIT
United States
# |
Name |
EBIT |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 15.88 B
|
Sept. 30, 2024 | USD 175.55 | -0.67% |
|
United States |
|
| 2 |
USD 8.11 B
|
Sept. 28, 2024 | USD 556.99 | 0.27% |
|
United States |
|
| 3 |
USD 7.47 B
|
Sept. 30, 2024 | USD 267.10 | -1.14% |
|
United States |
|
| 4 |
USD 6.94 B
|
Sept. 29, 2024 | USD 26.41 | -1.46% |
|
United States |
|
| 5 |
USD 4.91 B
|
Sept. 27, 2024 | USD 237.62 | -0.94% |
|
United States |
|
| 6 |
USD 4.45 B
|
Sept. 30, 2024 | USD 362.80 | 0.50% |
|
United States |
|
| 7 |
USD 4.36 B
|
Sept. 30, 2024 | USD 690.87 | -3.63% |
|
United States |
|
| 8 |
USD 3.35 B
|
Sept. 30, 2024 | USD 164.41 | -1.15% |
|
United States |
|
| 9 |
USD 2.27 B
|
Sept. 30, 2024 | USD 143.06 | -4.74% |
|
United States |
|
| 10 |
USD 2.10 B
|
Sept. 30, 2024 | USD 197.96 | -3.26% |
|
United States |
|
| 11 |
USD 1.65 B
|
Sept. 30, 2024 | USD 12.74 | -6.60% |
|
United States |
|
| 12 |
USD 1.54 B
|
Oct. 31, 2024 | USD 143.43 | 1.04% |
|
United States |
|
| 13 |
USD 1.44 B
|
Sept. 30, 2024 | USD 364.70 | 0.50% |
|
United States |
|
| 14 |
USD 1.41 B
|
Sept. 30, 2024 | USD 60.89 | 1.60% |
|
United States |
|
| 15 |
USD 1.16 B
|
Sept. 30, 2024 | USD 91.00 | 1.18% |
|
United States |
|
| 16 |
USD 792.10 M
|
Sept. 30, 2024 | USD 234.50 | 0.17% |
|
United States |
|
| 17 |
USD 762.90 M
|
Sept. 30, 2024 | USD 79.17 | -0.84% |
|
United States |
|
| 18 |
USD 717.71 M
|
Sept. 30, 2024 | USD 30.03 | 0.13% |
|
United States |
|
| 19 |
USD 689.70 M
|
Sept. 30, 2024 | USD 21.72 | -1.36% |
|
United States |
|
| 20 |
USD 650.21 M
|
Sept. 28, 2024 | USD 178.08 | -6.34% |
|
United States |
|
| 21 |
USD 608.28 M
|
Sept. 27, 2024 | USD 35.65 | 0.99% |
|
United States |
|
| 22 |
USD 589.83 M
|
Sept. 30, 2024 | USD 92.62 | -2.15% |
|
United States |
|
| 23 |
USD 493.04 M
|
Sept. 30, 2024 | USD 4.54 | -7.91% |
|
United States |
|
| 24 |
USD 488.84 M
|
Sept. 30, 2024 | USD 53.83 | -0.57% |
|
United States |
|
| 25 |
USD 407.64 M
|
Sept. 30, 2024 | USD 63.81 | -4.75% |
|
United States |
|
| 26 |
USD 395.61 M
|
Sept. 29, 2024 | USD 120.73 | -1.61% |
|
United States |
|
| 27 |
USD 365.40 M
|
Sept. 30, 2024 | USD 61.26 | -2.69% |
|
United States |
|
| 28 |
USD 298.00 M
|
Sept. 30, 2024 | USD 411.66 | -0.41% |
|
United States |
|
| 29 |
USD 260.65 M
|
Sept. 30, 2024 | USD 88.18 | 1.15% |
|
United States |
|
| 30 |
USD 236.58 M
|
Sept. 30, 2024 | USD 74.73 | -2.21% |
|
United States |
|
| 31 |
USD 211.59 M
|
Sept. 30, 2024 | USD 38.48 | 1.48% |
|
United States |
|
| 32 |
USD 198.34 M
|
Sept. 30, 2024 | USD 12.76 | -2.52% |
|
United States |
|
| 33 |
USD 180.10 M
|
Sept. 30, 2024 | USD 36.42 | -0.08% |
|
United States |
|
| 34 |
USD 174.10 M
|
Sept. 30, 2024 | USD 158.62 | 1.47% |
|
United States |
|
| 35 |
USD 164.40 M
|
Sept. 30, 2024 | USD 22.19 | -0.09% |
|
United States |
|
| 36 |
USD 148.22 M
|
Sept. 30, 2024 | USD 36.67 | -1.26% |
|
United States |
|
| 37 |
USD 142.60 M
|
Sept. 30, 2024 | USD 51.66 | 1.18% |
|
United States |
|
| 38 |
USD 132.13 M
|
Sept. 30, 2024 | USD 71.93 | -0.61% |
|
United States |
|
| 39 |
USD 129.44 M
|
Sept. 30, 2024 | USD 118.83 | 0.34% |
|
United States |
|
| 40 |
USD 112.23 M
|
Sept. 30, 2024 | USD 16.90 | -5.59% |
|
United States |
|
| 41 |
USD 104.57 M
|
Sept. 30, 2024 | USD 6.33 | 4.46% |
|
United States |
|
| 42 |
USD 104.11 M
|
Sept. 30, 2024 | USD 3.65 | -3.18% |
|
United States |
|
| 43 |
USD 90.27 M
|
Sept. 30, 2024 | USD 16.32 | -1.03% |
|
United States |
|
| 44 |
USD 62.86 M
|
Sept. 30, 2024 | USD 8.61 | 0.58% |
|
United States |
|
| 45 |
USD 57.36 M
|
Sept. 30, 2024 | USD 142.64 | -5.10% |
|
United States |
|
| 46 |
USD 56.88 M
|
Sept. 30, 2024 | USD 12.49 | -6.58% |
|
United States |
|
| 47 |
USD 51.79 M
|
Sept. 30, 2024 | USD 6.03 | -1.63% |
|
United States |
|
| 48 |
USD 47.67 M
|
Sept. 30, 2024 | USD 17.21 | -1.54% |
|
United States |
|
| 49 |
USD 37.12 M
|
Sept. 30, 2024 | USD 3.09 | 0.33% |
|
United States |
|
| 50 |
USD 36.32 M
|
Sept. 30, 2024 | USD 62.54 | -2.36% |
|
United States |
Frequently Asked Questions
-
Which Biotechnology company in United States has the highest EBIT ?
The Biotechnology company in United States with the highest EBIT is AbbVie Inc. (NYSE: ABBV) at USD 15.88 B.
-
Which Biotechnology company in United States has the lowest EBIT ?
The Biotechnology company in United States with the lowest EBIT is Bristol-Myers Squibb Company (NYSE: BMY) at USD -5.11 B.
-
What are the top 10 Biotechnology companies in United States by EBIT ?
The top 10 Biotechnology companies in United States by EBIT are AbbVie Inc., Thermo Fisher Scientific Inc., Amgen Inc., Pfizer Inc., Danaher Corporation, Stryker Corporation, Regeneron Pharmaceuticals, Inc., Zoetis Inc., Biogen Inc. and IQVIA Holdings Inc..
-
What are the bottom 10 Biotechnology companies in United States by EBIT ?
The bottom 10 Biotechnology companies in United States by EBIT are Bristol-Myers Squibb Company, Moderna, Inc., QuidelOrtho Corporation, Illumina, Inc., Bio-Rad Laboratories, Inc., Biohaven Pharmaceutical Holding Company Ltd., GRAIL, LLC, Insmed Incorporated, Tempus AI, Inc. and Ginkgo Bioworks Holdings, Inc..